Over a year ago now, closer to two really, I asked the then CEO...

Over a year ago now, closer to two really, I asked the then CEO of Novogen whether it would be possible to use a confocal laser microscope like Optiscan had for looking at cancers and stem cells? he didn't reply to my question, which I found unusual, because generally he was very good at replying to shareholders, looking at this I know why he didn't reply now, I suspect that this is exactly what they were doing, but he couldn't tell me, I believe this will be the makings of OIL at long last?

"MR Solutions, the world leader in preclinical scanning, has partnered with Optiscan1 to introduce CellLiveTM, their second generation endomicroscopy platform to the preclinical market. The handheld Optiscan probe which is less than 3.6 mm in diameter delivers micron – smaller than a millionth of a metre - resolution. The Optiscan uses a fluorescence2, confocal3 imaging system to achieve this extraordinary level of detail imaging.

This new scanning technique will be particularly valuable to researchers tackling the complexities of translational medicine – taking science to the bedside - and drug development in diverse areas; including cancer, tissue engineering, inflammation, vascular disease and neuroscience. While conventional fluorescence microscopy enjoys widespread use in all of these applications, CellLIVE can be used where bench microscopes are too cumbersome - taking the microscope to the tissue.

For example, in regenerative medicine research, it is possible with CellLIVE to track the migration of stem cells and cellular interactions during implantation. In cancer research, it is possible to track the cellular interactions of candidate therapeutic interaction. And, in the study of inflammation, the migration of inflammatory cells in living systems can be directly observed.